PF
INDP icon

Phoenix Financial’s Indaptus Therapeutics INDP Stock Holding History

Phoenix Financial’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-268
Closed -$112K – 336
2020
Q1 		$112K Buy
268
+204
+319% +$154K 0.01% 296
2019
Q4 		$72K Buy
64
+49
+327% +$67.6K ﹤0.01% 194
2019
Q3 		$23K Buy
+15
New +$44.6K ﹤0.01% 190

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Phoenix Financial's INDP Position: Q2 2020 in Review

Phoenix Financial sold out of Indaptus Therapeutics (INDP) in Q2 2020, closing a stake of 268 shares — an estimated $112K sold.

Phoenix Financial first reported a position in INDP in Q3 2019 and held it in 3 quarters. The position peaked at $112K in Q1 2020. 26 funds tracked by Wall St. Rank hold INDP as of Q2 2020.

  • Phoenix Financial reported no remaining Indaptus Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Phoenix Financial sold 268 Indaptus Therapeutics shares in Q2 2020, an estimated $112K.
  • Phoenix Financial first reported a position in Indaptus Therapeutics in Q3 2019 and held it in 3 quarters.
  • Phoenix Financial's Indaptus Therapeutics position peaked at $112K in Q1 2020.
  • 26 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2020.

Based on Phoenix Financial's 13F filing for Q2 2020, filed 10 Aug 2020.